Inc.), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, ...

Israeli prisons continue to function as a network of torture camps for Palestinian detainees, with extensive systematic abuse ...

“Stem cell therapy and research are still effectively banned in South Africa,” Dr Mia said. “That hasn’t changed in law. What ...

The Global Central Nervous System Therapeutics Market is poised for growth driven by an aging population and heightened ...

The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...

A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with ...

Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) ...

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell ...

Congenital heart disease (CHD) is the most common birth defect and a lifelong condition for a growing number of patients ...

The Cord Blood Council (CBC), a new capacity building nonprofit, has launched to support the nation’s public cord blood banks. The organization develops and provides shared resources to National Cord ...